 | • レポートコード：MRC2Q12-17108 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、セルフリーDNA（cfDNA）キットのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 セルフリーDNA（cfDNA）キットのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 セルフリーDNA（cfDNA）キットの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 セルフリーDNA（cfDNA）キットのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのセルフリーDNA（cfDNA）キットの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のセルフリーDNA（cfDNA）キットの売上および2028年までの予測に焦点を当てています。 セルフリーDNA（cfDNA）キットのグローバル主要企業には、Qiagen、Thermo Scientific、Norgen Biotek、Agilent、Zymo Research、Apostle、Bioneer、Covaris、Amsbio、Active Motif、EpiGentek、Shanghai Runyu Biotechnology、Geneseeq Technology、Suzhou Beaver Biomedical Engineeringなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 セルフリーDNA（cfDNA）キット市場は、タイプとアプリケーションによって区分されます。世界のセルフリーDNA（cfDNA）キット市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 5ml以下、5ml以上 【アプリケーション別セグメント】 人間、動物 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - セルフリーDNA（cfDNA）キット製品概要 - タイプ別市場（5ml以下、5ml以上） - アプリケーション別市場（人間、動物） - 調査の目的 ・エグゼクティブサマリー - 世界のセルフリーDNA（cfDNA）キット販売量予測2017-2028 - 世界のセルフリーDNA（cfDNA）キット売上予測2017-2028 - セルフリーDNA（cfDNA）キットの地域別販売量 - セルフリーDNA（cfDNA）キットの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別セルフリーDNA（cfDNA）キット販売量 - 主要メーカー別セルフリーDNA（cfDNA）キット売上 - 主要メーカー別セルフリーDNA（cfDNA）キット価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（5ml以下、5ml以上） - セルフリーDNA（cfDNA）キットのタイプ別販売量 - セルフリーDNA（cfDNA）キットのタイプ別売上 - セルフリーDNA（cfDNA）キットのタイプ別価格 ・アプリケーション別市場規模（人間、動物） - セルフリーDNA（cfDNA）キットのアプリケーション別販売量 - セルフリーDNA（cfDNA）キットのアプリケーション別売上 - セルフリーDNA（cfDNA）キットのアプリケーション別価格 ・北米市場 - 北米のセルフリーDNA（cfDNA）キット市場規模（タイプ別、アプリケーション別） - 主要国別のセルフリーDNA（cfDNA）キット市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのセルフリーDNA（cfDNA）キット市場規模（タイプ別、アプリケーション別） - 主要国別のセルフリーDNA（cfDNA）キット市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のセルフリーDNA（cfDNA）キット市場規模（タイプ別、アプリケーション別） - 主要国別のセルフリーDNA（cfDNA）キット市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のセルフリーDNA（cfDNA）キット市場規模（タイプ別、アプリケーション別） - 主要国別のセルフリーDNA（cfDNA）キット市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのセルフリーDNA（cfDNA）キット市場規模（タイプ別、アプリケーション別） - 主要国別のセルフリーDNA（cfDNA）キット市場規模（トルコ、サウジアラビア） ・企業情報 Qiagen、Thermo Scientific、Norgen Biotek、Agilent、Zymo Research、Apostle、Bioneer、Covaris、Amsbio、Active Motif、EpiGentek、Shanghai Runyu Biotechnology、Geneseeq Technology、Suzhou Beaver Biomedical Engineering ・産業チェーン及び販売チャネル分析 - セルフリーDNA（cfDNA）キットの産業チェーン分析 - セルフリーDNA（cfDNA）キットの原材料 - セルフリーDNA（cfDNA）キットの生産プロセス - セルフリーDNA（cfDNA）キットの販売及びマーケティング - セルフリーDNA（cfDNA）キットの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - セルフリーDNA（cfDNA）キットの産業動向 - セルフリーDNA（cfDNA）キットのマーケットドライバー - セルフリーDNA（cfDNA）キットの課題 - セルフリーDNA（cfDNA）キットの阻害要因 ・主な調査結果 |
Cell-free DNA (cfDNA) Kits Are Designed to Efficiently Isolate Free Dna (cfDNA) from Serum or Plasma Samples. Cell-free DNA (cfDNA) Circulates in Extracellular Plasma, and Epigenetic Markers Found on cfDNA, Such As DNA Methylation, Can Be Used As Powerful Sample Types for Disease Diagnosis As Biomarkers for Cancer, Pregnancy, and Aging. Whereas This Approach is Inherently Limited by the Amount of cfDNA Isolated from the Sample, It is Important to Maximize the Retention of cfDNA when Purifying It from the Sample.
Market Analysis and Insights: Global Cell-Free DNA (cfDNA) Kits Market
Due to the COVID-19 pandemic, the global Cell-Free DNA (cfDNA) Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Less than 5ml accounting for % of the Cell-Free DNA (cfDNA) Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Human segment is altered to an % CAGR throughout this forecast period.
China Cell-Free DNA (cfDNA) Kits market size is valued at US$ million in 2021, while the US and Europe Cell-Free DNA (cfDNA) Kits are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cell-Free DNA (cfDNA) Kits landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Cell-Free DNA (cfDNA) Kits include Qiagen, Thermo Scientific, Norgen Biotek, Agilent, Zymo Research, Apostle, Bioneer, Covaris and Amsbio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Cell-Free DNA (cfDNA) Kits Scope and Segment
Cell-Free DNA (cfDNA) Kits market is segmented by Maximum Sample Volume and by Application. Players, stakeholders, and other participants in the global Cell-Free DNA (cfDNA) Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Maximum Sample Volume and by Application for the period 2017-2028.
Segment by Maximum Sample Volume
Less than 5ml
More than 5ml
Segment by Application
Human
Animal
By Company
Qiagen
Thermo Scientific
Norgen Biotek
Agilent
Zymo Research
Apostle
Bioneer
Covaris
Amsbio
Active Motif
EpiGentek
Shanghai Runyu Biotechnology
Geneseeq Technology
Suzhou Beaver Biomedical Engineering
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Cell-Free DNA (cfDNA) Kits Product Introduction
1.2 Market by Maximum Sample Volume
1.2.1 Global Cell-Free DNA (cfDNA) Kits Market Size Growth Rate by Maximum Sample Volume, 2017 VS 2021 VS 2028
1.2.2 Less than 5ml
1.2.3 More than 5ml
1.3 Market by Application
1.3.1 Global Cell-Free DNA (cfDNA) Kits Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Human
1.3.3 Animal
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cell-Free DNA (cfDNA) Kits Sales Estimates and Forecasts 2017-2028
2.2 Global Cell-Free DNA (cfDNA) Kits Revenue Estimates and Forecasts 2017-2028
2.3 Global Cell-Free DNA (cfDNA) Kits Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cell-Free DNA (cfDNA) Kits Sales by Region
2.4.1 Global Cell-Free DNA (cfDNA) Kits Sales by Region (2017-2022)
2.4.2 Global Sales Cell-Free DNA (cfDNA) Kits by Region (2023-2028)
2.5 Global Cell-Free DNA (cfDNA) Kits Revenue by Region
2.5.1 Global Cell-Free DNA (cfDNA) Kits Revenue by Region (2017-2022)
2.5.2 Global Cell-Free DNA (cfDNA) Kits Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cell-Free DNA (cfDNA) Kits Sales by Manufacturers
3.1.1 Global Top Cell-Free DNA (cfDNA) Kits Manufacturers by Sales (2017-2022)
3.1.2 Global Cell-Free DNA (cfDNA) Kits Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cell-Free DNA (cfDNA) Kits in 2021
3.2 Global Cell-Free DNA (cfDNA) Kits Revenue by Manufacturers
3.2.1 Global Cell-Free DNA (cfDNA) Kits Revenue by Manufacturers (2017-2022)
3.2.2 Global Cell-Free DNA (cfDNA) Kits Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cell-Free DNA (cfDNA) Kits Revenue in 2021
3.3 Global Cell-Free DNA (cfDNA) Kits Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cell-Free DNA (cfDNA) Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cell-Free DNA (cfDNA) Kits Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Maximum Sample Volume
4.1 Global Cell-Free DNA (cfDNA) Kits Sales by Maximum Sample Volume
4.1.1 Global Cell-Free DNA (cfDNA) Kits Historical Sales by Maximum Sample Volume (2017-2022)
4.1.2 Global Cell-Free DNA (cfDNA) Kits Forecasted Sales by Maximum Sample Volume (2023-2028)
4.1.3 Global Cell-Free DNA (cfDNA) Kits Sales Market Share by Maximum Sample Volume (2017-2028)
4.2 Global Cell-Free DNA (cfDNA) Kits Revenue by Maximum Sample Volume
4.2.1 Global Cell-Free DNA (cfDNA) Kits Historical Revenue by Maximum Sample Volume (2017-2022)
4.2.2 Global Cell-Free DNA (cfDNA) Kits Forecasted Revenue by Maximum Sample Volume (2023-2028)
4.2.3 Global Cell-Free DNA (cfDNA) Kits Revenue Market Share by Maximum Sample Volume (2017-2028)
4.3 Global Cell-Free DNA (cfDNA) Kits Price by Maximum Sample Volume
4.3.1 Global Cell-Free DNA (cfDNA) Kits Price by Maximum Sample Volume (2017-2022)
4.3.2 Global Cell-Free DNA (cfDNA) Kits Price Forecast by Maximum Sample Volume (2023-2028)
5 Market Size by Application
5.1 Global Cell-Free DNA (cfDNA) Kits Sales by Application
5.1.1 Global Cell-Free DNA (cfDNA) Kits Historical Sales by Application (2017-2022)
5.1.2 Global Cell-Free DNA (cfDNA) Kits Forecasted Sales by Application (2023-2028)
5.1.3 Global Cell-Free DNA (cfDNA) Kits Sales Market Share by Application (2017-2028)
5.2 Global Cell-Free DNA (cfDNA) Kits Revenue by Application
5.2.1 Global Cell-Free DNA (cfDNA) Kits Historical Revenue by Application (2017-2022)
5.2.2 Global Cell-Free DNA (cfDNA) Kits Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cell-Free DNA (cfDNA) Kits Revenue Market Share by Application (2017-2028)
5.3 Global Cell-Free DNA (cfDNA) Kits Price by Application
5.3.1 Global Cell-Free DNA (cfDNA) Kits Price by Application (2017-2022)
5.3.2 Global Cell-Free DNA (cfDNA) Kits Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cell-Free DNA (cfDNA) Kits Market Size by Maximum Sample Volume
6.1.1 North America Cell-Free DNA (cfDNA) Kits Sales by Maximum Sample Volume (2017-2028)
6.1.2 North America Cell-Free DNA (cfDNA) Kits Revenue by Maximum Sample Volume (2017-2028)
6.2 North America Cell-Free DNA (cfDNA) Kits Market Size by Application
6.2.1 North America Cell-Free DNA (cfDNA) Kits Sales by Application (2017-2028)
6.2.2 North America Cell-Free DNA (cfDNA) Kits Revenue by Application (2017-2028)
6.3 North America Cell-Free DNA (cfDNA) Kits Market Size by Country
6.3.1 North America Cell-Free DNA (cfDNA) Kits Sales by Country (2017-2028)
6.3.2 North America Cell-Free DNA (cfDNA) Kits Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Cell-Free DNA (cfDNA) Kits Market Size by Maximum Sample Volume
7.1.1 Europe Cell-Free DNA (cfDNA) Kits Sales by Maximum Sample Volume (2017-2028)
7.1.2 Europe Cell-Free DNA (cfDNA) Kits Revenue by Maximum Sample Volume (2017-2028)
7.2 Europe Cell-Free DNA (cfDNA) Kits Market Size by Application
7.2.1 Europe Cell-Free DNA (cfDNA) Kits Sales by Application (2017-2028)
7.2.2 Europe Cell-Free DNA (cfDNA) Kits Revenue by Application (2017-2028)
7.3 Europe Cell-Free DNA (cfDNA) Kits Market Size by Country
7.3.1 Europe Cell-Free DNA (cfDNA) Kits Sales by Country (2017-2028)
7.3.2 Europe Cell-Free DNA (cfDNA) Kits Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cell-Free DNA (cfDNA) Kits Market Size by Maximum Sample Volume
8.1.1 Asia Pacific Cell-Free DNA (cfDNA) Kits Sales by Maximum Sample Volume (2017-2028)
8.1.2 Asia Pacific Cell-Free DNA (cfDNA) Kits Revenue by Maximum Sample Volume (2017-2028)
8.2 Asia Pacific Cell-Free DNA (cfDNA) Kits Market Size by Application
8.2.1 Asia Pacific Cell-Free DNA (cfDNA) Kits Sales by Application (2017-2028)
8.2.2 Asia Pacific Cell-Free DNA (cfDNA) Kits Revenue by Application (2017-2028)
8.3 Asia Pacific Cell-Free DNA (cfDNA) Kits Market Size by Region
8.3.1 Asia Pacific Cell-Free DNA (cfDNA) Kits Sales by Region (2017-2028)
8.3.2 Asia Pacific Cell-Free DNA (cfDNA) Kits Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Cell-Free DNA (cfDNA) Kits Market Size by Maximum Sample Volume
9.1.1 Latin America Cell-Free DNA (cfDNA) Kits Sales by Maximum Sample Volume (2017-2028)
9.1.2 Latin America Cell-Free DNA (cfDNA) Kits Revenue by Maximum Sample Volume (2017-2028)
9.2 Latin America Cell-Free DNA (cfDNA) Kits Market Size by Application
9.2.1 Latin America Cell-Free DNA (cfDNA) Kits Sales by Application (2017-2028)
9.2.2 Latin America Cell-Free DNA (cfDNA) Kits Revenue by Application (2017-2028)
9.3 Latin America Cell-Free DNA (cfDNA) Kits Market Size by Country
9.3.1 Latin America Cell-Free DNA (cfDNA) Kits Sales by Country (2017-2028)
9.3.2 Latin America Cell-Free DNA (cfDNA) Kits Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cell-Free DNA (cfDNA) Kits Market Size by Maximum Sample Volume
10.1.1 Middle East and Africa Cell-Free DNA (cfDNA) Kits Sales by Maximum Sample Volume (2017-2028)
10.1.2 Middle East and Africa Cell-Free DNA (cfDNA) Kits Revenue by Maximum Sample Volume (2017-2028)
10.2 Middle East and Africa Cell-Free DNA (cfDNA) Kits Market Size by Application
10.2.1 Middle East and Africa Cell-Free DNA (cfDNA) Kits Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cell-Free DNA (cfDNA) Kits Revenue by Application (2017-2028)
10.3 Middle East and Africa Cell-Free DNA (cfDNA) Kits Market Size by Country
10.3.1 Middle East and Africa Cell-Free DNA (cfDNA) Kits Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cell-Free DNA (cfDNA) Kits Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Qiagen
11.1.1 Qiagen Corporation Information
11.1.2 Qiagen Overview
11.1.3 Qiagen Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Qiagen Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Qiagen Recent Developments
11.2 Thermo Scientific
11.2.1 Thermo Scientific Corporation Information
11.2.2 Thermo Scientific Overview
11.2.3 Thermo Scientific Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Thermo Scientific Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Thermo Scientific Recent Developments
11.3 Norgen Biotek
11.3.1 Norgen Biotek Corporation Information
11.3.2 Norgen Biotek Overview
11.3.3 Norgen Biotek Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Norgen Biotek Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Norgen Biotek Recent Developments
11.4 Agilent
11.4.1 Agilent Corporation Information
11.4.2 Agilent Overview
11.4.3 Agilent Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Agilent Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Agilent Recent Developments
11.5 Zymo Research
11.5.1 Zymo Research Corporation Information
11.5.2 Zymo Research Overview
11.5.3 Zymo Research Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Zymo Research Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zymo Research Recent Developments
11.6 Apostle
11.6.1 Apostle Corporation Information
11.6.2 Apostle Overview
11.6.3 Apostle Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Apostle Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Apostle Recent Developments
11.7 Bioneer
11.7.1 Bioneer Corporation Information
11.7.2 Bioneer Overview
11.7.3 Bioneer Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bioneer Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bioneer Recent Developments
11.8 Covaris
11.8.1 Covaris Corporation Information
11.8.2 Covaris Overview
11.8.3 Covaris Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Covaris Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Covaris Recent Developments
11.9 Amsbio
11.9.1 Amsbio Corporation Information
11.9.2 Amsbio Overview
11.9.3 Amsbio Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Amsbio Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amsbio Recent Developments
11.10 Active Motif
11.10.1 Active Motif Corporation Information
11.10.2 Active Motif Overview
11.10.3 Active Motif Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Active Motif Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Active Motif Recent Developments
11.11 EpiGentek
11.11.1 EpiGentek Corporation Information
11.11.2 EpiGentek Overview
11.11.3 EpiGentek Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 EpiGentek Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 EpiGentek Recent Developments
11.12 Shanghai Runyu Biotechnology
11.12.1 Shanghai Runyu Biotechnology Corporation Information
11.12.2 Shanghai Runyu Biotechnology Overview
11.12.3 Shanghai Runyu Biotechnology Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Shanghai Runyu Biotechnology Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shanghai Runyu Biotechnology Recent Developments
11.13 Geneseeq Technology
11.13.1 Geneseeq Technology Corporation Information
11.13.2 Geneseeq Technology Overview
11.13.3 Geneseeq Technology Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Geneseeq Technology Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Geneseeq Technology Recent Developments
11.14 Suzhou Beaver Biomedical Engineering
11.14.1 Suzhou Beaver Biomedical Engineering Corporation Information
11.14.2 Suzhou Beaver Biomedical Engineering Overview
11.14.3 Suzhou Beaver Biomedical Engineering Cell-Free DNA (cfDNA) Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Suzhou Beaver Biomedical Engineering Cell-Free DNA (cfDNA) Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Suzhou Beaver Biomedical Engineering Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cell-Free DNA (cfDNA) Kits Industry Chain Analysis
12.2 Cell-Free DNA (cfDNA) Kits Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cell-Free DNA (cfDNA) Kits Production Mode & Process
12.4 Cell-Free DNA (cfDNA) Kits Sales and Marketing
12.4.1 Cell-Free DNA (cfDNA) Kits Sales Channels
12.4.2 Cell-Free DNA (cfDNA) Kits Distributors
12.5 Cell-Free DNA (cfDNA) Kits Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cell-Free DNA (cfDNA) Kits Industry Trends
13.2 Cell-Free DNA (cfDNA) Kits Market Drivers
13.3 Cell-Free DNA (cfDNA) Kits Market Challenges
13.4 Cell-Free DNA (cfDNA) Kits Market Restraints
14 Key Findings in The Global Cell-Free DNA (cfDNA) Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer